Table 2.
Task Parameters, Performance, and Reliability on 5 Versions of the DPX
| Version | Trial-Type | Number of Trials (%) | Schizophrenia Patients |
Controls |
||
| % Errors (SD) | α | % Errors (SD) | α | |||
| Long forms (ISI 4000 ms) | ||||||
| Form 1 | AX | 88 (68.75) | 9.1 (8.1) | .87 | 3.7 (4.2) | .78 |
| AY | 16 (12.5) | 20.1 (17.0) | .71 | 10.3 (10.2) | .47 | |
| BX | 16 (12.5) | 19.9 (21.2) | .83 | 8.3 (12.5) | .74 | |
| BY | 8 (6.25) | 4.2 (8.5) | .32 | 0.9 (3.7) | .15 | |
| Form 2 | AX | 80 (62.5) | 10.2 (10.2) | .90 | 4.3 (5.1) | .80 |
| AY | 24 (18.75) | 14.1 (14.6) | .80 | 7.7 (9.2) | .68 | |
| BX | 16 (12.5) | 17.3 (19.7) | .82 | 9.5 (13.8) | .76 | |
| BY | 8 (6.25) | 5.9 (9.6) | .27 | 2.1 (6.5) | .43 | |
| Form 3 | AX | 76 (59.38) | 10.5 (10.1) | .90 | 5.2 (6.9) | .88 |
| AY | 24 (18.75) | 14.3 (14.2) | .78 | 6.6 (8.1) | .64 | |
| BX | 20 (15.63) | 20.5 (22.0) | .85 | 9.0 (12.9) | .80 | |
| BY | 8 (6.25) | 5.4 (10.3) | .43 | 1.8 (5.0) | .14 | |
| Short forms (ISI 2000 ms) | ||||||
| Form 1 | AX | 88 (68.75) | 9.1 (9.2) | .90 | 2.8 (3.9) | .80 |
| AY | 16 (12.5) | 18.1 (15.1) | .65 | 9.8 (5.0) | .39 | |
| BX | 16 (12.5) | 20.4 (20.4) | .79 | 7.8 (4.8) | .53 | |
| BY | 8 (6.25) | 7.1 (11.1) | .28 | 1.8 (7.4) | .21 | |
| Form 2 | AX | 80 (62.5) | 9.6 (9.9) | .90 | 3.2 (12.3) | .84 |
| AY | 24 (18.75) | 14.2 (13.1) | .74 | 6.2 (6.4) | .58 | |
| BX | 16 (12.5) | 20.2 (19.8) | .80 | 8.2 (5.0) | .73 | |
| BY | 8 (6.25) | 7.1 (10.3) | .27 | 2.1 (4.8) | .38 | |
Note: ISI, interstimulus interval (time between the offset of the cue and the onset of the probe, in milliseconds); Reliability is measured by Cronbach’s α for available participants; For all versions of the task, the number of trials was 128, cue length was 1000 ms, probe length was 500 ms, and intertrial interval was 1200 ms. Long form 1 represented the standard version of the task. The other task versions were developed by altering the standard version’s ISI and critical trial (AY or BX) frequencies. Long forms 2 and 3 were created by increasing the frequency of one (long form 2; AY trials) or both (long form 3; AY and BX trials) critical trials. Short form 1 was created by reducing the ISI, whereas short form 2 reduced ISI and increased AY trial frequency. AY or BX trial frequency increases were accommodated by a reduction in AX trial frequency (ie, the expectancy manipulation).